Katz R M
Hosp Pharm. 1980 Feb;15(2):62-7.
A study was conducted by two mental health institutions to determine the usage and the cost of providing oral solid unit dosage medications to 1400 patients. The results in the two institutions were as follows: 1) 257,732 (12%) and 73,956 (17%) doses were not commercially available; 2) 656 and 134 technician hours per year could be saved by employing a vendor packaging service; 3) only 119,802 (5%) and 66,627 (15%) of the doses were available commercially at little or no additional cost compared to bulk purchase; and 4) 1,856,752 (83%) and 298,712 (63%) doses were available commercially at a premium price of $34,138 and $8,544 per year. The unusually high quantity of medications not commercially available in unit dose packages and the high cost of purchasing those that are available may be the result of the specialized care provided by a mental health facility. Therefore, methods of providing unit dose products in acute-care hospitals may not be adaptable to mental health facilities or to other specialized care providers.
两家心理健康机构开展了一项研究，以确定为1400名患者提供口服固体单位剂量药物的使用情况和成本。两家机构的结果如下：1）257,732剂（12%）和73,956剂（17%）没有商业供应；2）通过采用供应商包装服务，每年可节省656和134个技术工时；3）与批量采购相比，只有119,802剂（5%）和66,627剂（15%）有少量或无额外成本的商业供应；4）1,856,752剂（83%）和298,712剂（63%）有商业供应，每年溢价分别为34,138美元和8,544美元。单位剂量包装中没有商业供应的药物数量异常之高，以及购买有商业供应的药物成本高昂，可能是心理健康机构提供的特殊护理所致。因此，急症医院提供单位剂量产品的方法可能不适用于心理健康机构或其他特殊护理提供者。
